Results 31 to 40 of about 22,933 (184)
International Journal of Infectious Diseases, 2023 Rifampicin-resistant tuberculosis (RR-TB) accounts for an expanding proportion of incident global TB cases and is a major barrier to global tuberculosis control. Conventional therapy for RR-TB is more toxic, less effective, and much more costly than drug-susceptible TB.
openaire +2 more sources
International Journal of Infectious Diseases, 2018 Objectives: This study compared the yield of tuberculosis (TB) among contacts of multidrug-resistant tuberculosis (MDR-TB) index cases with that in drug-sensitive TB (DS-TB) index cases in a program setting.
Nebiyu Hiruy +9 more
doaj +1 more source
MDR-TB in Pakistan: Challenges, efforts, and recommendations
Annals of Medicine & Surgery, 2022 Tuberculosis (TB), a global health concern is also a leading cause of mortality and morbidity across Pakistan affecting a major proportion of the population. The absence of an integrated system to control the spread of TB has led to a rise in multidrug resistant strains of TB (MDR-Tb) which do not exhibit any sensitivity towards the first line therapy ...
Khan, Mahad Ahmed +5 more
openaire +2 more sources
BMC Public Health, 2019 Background Multidrug-resistant tuberculosis (MDR-TB) is caused by bacteria that are resistant to the most effective anti-tuberculosis drug. The MDR-TB is an increasing global problem and the spread of MDR-TB has different recovery time for different ...
Yigzaw Alemu Limenih +1 more
doaj +1 more source
International Journal of Mycobacteriology, 2021 Background: Cases of tuberculosis (TB) and multidrug-resistant TB (MDR-TB) in South-east Asia including Indonesia are still high. The presence of mixed infections in TB cases has been reported. Several studies revealed the role of the human microbiome in
Nurul Wiqoyah +3 more
doaj +1 more source
Indian Journal of Respiratory Care, 2020 Introduction: Multidrug-resistant tuberculosis (MDR-TB) has created a significant health problem in most of the countries, and it is an obstacle to effective TB control.
Gauri Suhas Kulkarni +4 more
doaj +1 more source
Assessment of the risk factors associated with multidrug-resistant tuberculosis in Sudan: a case-control study [PDF]
Epidemiology and Health, 2019 OBJECTIVES The emergence of multidrug-resistant tuberculosis (MDR-TB) is a major challenge for the global control of tuberculosis (TB). The aim of this study was to determine the risk factors associated with MDR-TB in Sudan.
Adel Hussein Elduma +6 more
doaj +1 more source
Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006–2019
Emerging Infectious Diseases, 2022 Definitions of resistance in multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XDR TB) have been updated. Pre–XDR TB, defined as MDR TB with additional resistance to fluoroquinolones, and XDR TB, with additional ...
Yousra Kherabi +7 more
doaj +1 more source
Risk for multidrug-resistant tuberculosis in patients treated with anti-tumor necrosis factor agents
Frontiers in Medicine, 2023 BackgroundThere are few studies on medical conditions associated with the development of drug-resistant TB.ObjectiveWe investigated the risk factors for the occurrence of multidrug-resistant (MDR) tuberculosis (TB) in patients with pulmonary TB.Materials
Jinkyeong Park +2 more
doaj +1 more source
Multiple Introductions of Multidrug-Resistant Tuberculosis into Households, Lima, Peru
Emerging Infectious Diseases, 2011 Two cases of multidrug-resistant tuberculosis (MDR TB) in a household are assumed to reflect within-household transmission. However, in high-incidence areas of MDR TB, secondary cases may arise through exposure to MDR TB in the community. To estimate the
Ted Cohen +8 more
doaj +1 more source